A.
Research progress of the selective sphingosine-1-phosphate receptor 1 agonists
B.
Systematic review and meta-ysis of randomized controlled trials of Chinese herbal medicine in treatment of multiple sclerosis
C.
Equivalence of glatiramer acetate products: challenges in assessing pharmaceutical equivalence and critical clinical performance attributes
D.
Ocrelizumab: A New B-cell Therapy for Relapsing Remitting and Primary Progressive Multiple Sclerosis. Ann Pharmacother
E.
Multiple sclerosis, a treatable disease